Editorial office note: Figure 3 in this manuscript appears as Table 3 in the print version of this article.
The authors thank the patient for willingness to share the case history and photographs for publication. We would like to thank Editage (www.editage.com) for English language editing.
Warrell DA, Ormerod LD, Davidson NM, 1975. Bites by puff-adder (Bitis arietans) in Nigeria, and value of antivenom. BMJ 4: 697–700.
Bey TA, Boyer LV, Walter FG, McNally J, Desai H, 1997. Exotic snakebite: envenomation by an African puff adder (Bitis arietans). J Emerg Med 15: 827–831.
Lavonas EJ, Tomaszewski CA, Ford MD, Rouse AM, Kerns WP II, 2002. Severe puff adder (Bitis arietans) envenomation with coagulopathy. J Toxicol Clin Toxicol 40: 911–918.
Schaeffer RC, Chilton SM, Carlson RW, 1985. Puff adder venom shock: a model of increased vascular permeability. J Pharmacol Exp Ther 233: 312–317.
Rainer PP, Kaufmann P, Smolle-Juettner FM, Krejs GJ, 2010. Case report: hyperbaric oxygen in the treatment of puff adder (Bitis arietans) bite. Undersea Hyperb Med 37: 395–398.
Korambayil PM, Ambookan PV, Abraham SV, Ambalakat A, 2015. A multidisciplinary approach with hyperbaric oxygen therapy improve outcome in snake bite injuries. Toxicol Int 22: 104–109.
Maduwage K, Isbister GK, 2014. Current treatment for venom-induced consumption coagulopathy resulting from snakebite. PLoS Negl Trop Dis 8: e3220.
Yamakawa K et al., 2013. Recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis. Intensive Care Med 39: 644–652.
Ichiki T, Kohda F, Hiramatsu T, Saiki R, Sakai A, Furue M, 2019. Early pathology in venom-induced consumption coagulopathy by Rhabdophis tigrinus (Yamakagashi snake) envenomation. Clin Toxicol (Phila) 57: 668–671.